Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Elimination of Inter-Segment Transactions	-6.29B	-5.42B	-4.18B	-3.19B	-3.42B
Construction and Facility Maintenance	7.38B	5.99B	4.92B	3.28B	4.33B
Construction and Facility Maintenance Growth	23.32%	21.77%	50.08%	-24.38%	-6.64%
Pharmaceuticals	77.95B	75.30B	63.35B	56.24B	54.15B
Pharmaceuticals Growth	3.52%	18.87%	12.63%	3.87%	-4.01%
Merchandising	1.14B	1.07B	983.00M	824.00M	763.00M
Merchandising Growth	6.46%	8.65%	19.30%	7.99%	-60.97%
Information Service	17.23B	11.40B	10.51B	10.34B	9.56B
Information Service Growth	51.16%	8.41%	1.63%	8.16%	-8.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error